Clinical Trial Update: Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 pilot trial evaluated ferric carboxymaltose for treating iron deficiency in Asian patients with heart failure; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Iron Deficiency Anemia

Drugs mentioned

• Ferric carboxymaltose (ferric carboxymaltose)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Heart Failure, Anemia | Phase 4 | Status: COMPLETED